Annual Cash & Cash Equivalents
$95.00 M
+$39.59 M+71.46%
31 December 2023
Summary:
UroGen Pharma annual cash & cash equivalents is currently $95.00 million, with the most recent change of +$39.59 million (+71.46%) on 31 December 2023. During the last 3 years, it has risen by +$42.14 million (+79.71%). URGN annual cash & cash equivalents is now -6.23% below its all-time high of $101.32 million, reached on 31 December 2018.URGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$124.92 M
-$95.06 M-43.21%
30 September 2024
Summary:
UroGen Pharma quarterly cash and cash equivalents is currently $124.92 million, with the most recent change of -$95.06 million (-43.21%) on 30 September 2024. Over the past year, it has increased by +$5.61 million (+4.70%). URGN quarterly cash and cash equivalents is now -49.36% below its all-time high of $246.69 million, reached on 31 March 2019.URGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.5% | +4.7% |
| 3 y3 years | +79.7% | +125.7% |
| 5 y5 years | -6.2% | +88.8% |
URGN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +114.2% | -43.2% | +520.6% |
| 5 y | 5 years | -6.2% | +114.2% | -43.2% | +520.6% |
| alltime | all time | -6.2% | +428.5% | -49.4% | +520.6% |
UroGen Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $124.92 M(-43.2%) |
| June 2024 | - | $219.97 M(+67.4%) |
| Mar 2024 | - | $131.44 M(+38.4%) |
| Dec 2023 | $95.00 M(+71.5%) | $95.00 M(-20.4%) |
| Sept 2023 | - | $119.31 M(+492.8%) |
| June 2023 | - | $20.13 M(-44.9%) |
| Mar 2023 | - | $36.54 M(-34.1%) |
| Dec 2022 | $55.41 M(+24.9%) | $55.41 M(+93.2%) |
| Sept 2022 | - | $28.69 M(-64.4%) |
| June 2022 | - | $80.69 M(-23.4%) |
| Mar 2022 | - | $105.38 M(+137.6%) |
| Dec 2021 | $44.36 M(-16.1%) | $44.36 M(-19.8%) |
| Sept 2021 | - | $55.34 M(-12.6%) |
| June 2021 | - | $63.32 M(+56.4%) |
| Mar 2021 | - | $40.49 M(-23.4%) |
| Dec 2020 | $52.86 M | $52.86 M(+115.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $24.57 M(-32.4%) |
| June 2020 | - | $36.35 M(+37.3%) |
| Mar 2020 | - | $26.47 M(-46.7%) |
| Dec 2019 | $49.69 M(-51.0%) | $49.69 M(-24.9%) |
| Sept 2019 | - | $66.15 M(-26.8%) |
| June 2019 | - | $90.42 M(-63.3%) |
| Mar 2019 | - | $246.69 M(+143.5%) |
| Dec 2018 | $101.32 M(+173.8%) | $101.32 M(-7.5%) |
| Sept 2018 | - | $109.48 M(-8.1%) |
| June 2018 | - | $119.11 M(-6.6%) |
| Mar 2018 | - | $127.46 M(+244.5%) |
| Dec 2017 | $37.00 M(+73.2%) | $37.00 M(-53.3%) |
| Sept 2017 | - | $79.17 M(+2.7%) |
| June 2017 | - | $77.09 M(+260.9%) |
| Dec 2016 | $21.36 M(+18.8%) | $21.36 M |
| Dec 2015 | $17.98 M | - |
FAQ
- What is UroGen Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for UroGen Pharma?
- What is UroGen Pharma annual cash & cash equivalents year-on-year change?
- What is UroGen Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for UroGen Pharma?
- What is UroGen Pharma quarterly cash and cash equivalents year-on-year change?
What is UroGen Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of URGN is $95.00 M
What is the all time high annual cash & cash equivalents for UroGen Pharma?
UroGen Pharma all-time high annual cash & cash equivalents is $101.32 M
What is UroGen Pharma annual cash & cash equivalents year-on-year change?
Over the past year, URGN annual cash & cash equivalents has changed by +$39.59 M (+71.46%)
What is UroGen Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of URGN is $124.92 M
What is the all time high quarterly cash and cash equivalents for UroGen Pharma?
UroGen Pharma all-time high quarterly cash and cash equivalents is $246.69 M
What is UroGen Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, URGN quarterly cash and cash equivalents has changed by +$5.61 M (+4.70%)